79282685
Feb 13, 2020
Oct 12, 2021
CANOPY IMMUNO-THERAPEUTICS LTD.
Active Trademark
Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials for the treatment of autoimmune diseases and disorders; Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials for the treatment of autoimmune diseases, by eliminating specific lymphocytes' lineages or modulating the immune response using a variety of organic compounds and recombinant proteins; Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials that modulate the immune system by recombinant proteins that contain a targeting moiety and an effect or moiety to eliminate specific lymphocytes' lineages and attenuate or block antibody creation and antigen-specific immune response in autoimmune diseases for the treatment of autoimmune diseases and disorders; Pharmaceutical recombinant proteins and substances not related to pharmaceuticals and clinical trials that modulate the immune system by recombinant proteins that contain a targeting moiety and an effect or moiety to eliminate specific lymphocytes lineages and attenuate or block the creation of the antibodies IgG, IgE or IgA and antigen-specific immune response in autoimmune diseases for the treatment of autoimmune diseases and disorders; Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials with potential immunomodulation activity to treat under and over responsiveness of the immune system for the treatment of autoimmune diseases and disorders
Pharmaceuticals